ROP39 is an Irgb10-specific parasite effector that modulates acute Toxoplasma gondii virulence
PLOS Pathogens · 05.01.2023 · 19 (1) · e1011003
DOI: 10.1371/journal.ppat.1011003 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 05.01.2023. Verfasst von Shishir Singh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Virology, Medical Center University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Toxoplasma, Parasites, Toxoplasmosis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIAID NIH HHS, Deutsche Forschungsgemeinschaft, German Academic Exchange Service.
Abstract (Originalsprache)
Toxoplasma gondii ( T . gondii ) is a zoonotic apicomplexan parasite that is an important cause of clinical disability in humans. On a global scale, one third of the human population is infected with T . gondii . Mice and other small rodents are believed to be responsible for transmission of T . gondii to the domestic cat, its definitive host. Interferon-inducible Immunity-Related GTPases (IRG proteins) are important for control of murine T . gondii infections. Virulence differences between T . gondii strains are linked to polymorphic rhoptry proteins (ROPs) that cooperate to inactivate individual IRG family members. In particular, the pseudokinase ROP5 isoform B is critically important in laboratory strains of mice. We identified T . gondii ROP39 in complex with ROP5B and demonstrate its contribution to acute T . gondii virulence. ROP39 directly targets Irgb10 and inhibits homodimer formation of the GTPase leading to an overall reduction of IRG protein loading onto the parasitophorous vacuolar membrane (PVM). Maintenance of PVM integrity rescues the parasite from IRG protein-mediated clearance in vitro and in vivo . This study identifies a novel T . gondii effector that is important for specific inactivation of the IRG resistance system. Our data reveal that yet unknown T . gondii effectors can emerge from identification of direct interaction partners of ROP5B.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Virology, Medical Center University of Freiburg, Freiburg, Germany.
- Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- Faculty of Biology, University of Freiburg, Freiburg, Germany.
- Grupo GEPAMOL, Centro de Investigaciones Biomedicas, Universidad del Quindio, Armenia, Quindio, Colombia.
- Department of Immunology, St. Jude Children´s Research Hospital, Memphis, Tenessee, United States of America.
- Department of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
ORCID-Profile: Shishir Singh, Mateo Murillo-León, Niklas Sebastian Endres, Jorge Enrique Gómez-Marín, Tobias Steinfeldt
Förderung
- NIAID NIH HHS
- Deutsche Forschungsgemeinschaft
- German Academic Exchange Service
- Medical Faculty of the University of Freiburg
Zitieren
APA
Singh, S., Murillo-León, M., Endres, N. S., Arenas Soto, A. F., Gómez-Marín, J. E., Melbert, F., Kanneganti, T. D., Yamamoto, M., Campos, C., Howard, J. C., Taylor, G. A., & Steinfeldt, T. (2023). ROP39 is an Irgb10-specific parasite effector that modulates acute Toxoplasma gondii virulence. PLOS Pathogens, 19(1), e1011003. https://doi.org/10.1371/journal.ppat.1011003
Vancouver
Singh S, Murillo-León M, Endres NS, Arenas Soto AF, Gómez-Marín JE, Melbert F, et al. ROP39 is an Irgb10-specific parasite effector that modulates acute Toxoplasma gondii virulence. PLOS Pathogens. 2023;19(1):e1011003. doi:10.1371/journal.ppat.1011003
BibTeX
@article{Singh2023,
author = {Singh, Shishir and Murillo-León, Mateo and Endres, Niklas Sebastian and Arenas Soto, Ailan Farid and Gómez-Marín, Jorge Enrique and Melbert, Florence and Kanneganti, Thirumala-Devi and Yamamoto, Masahiro and Campos, Claudia and Howard, Jonathan Charles and Taylor, Gregory Alan and Steinfeldt, Tobias},
title = {ROP39 is an Irgb10-specific parasite effector that modulates acute Toxoplasma gondii virulence},
journal = {PLOS Pathogens},
year = {2023},
volume = {19},
number = {1},
pages = {e1011003},
doi = {10.1371/journal.ppat.1011003}
}
EUVIMED